(NASDAQ: IMCC) IM Cannabis's forecast annual revenue growth rate of 49.49% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.69%.
IM Cannabis's revenue in 2025 is $37,521,527.On average, 1 Wall Street analysts forecast IMCC's revenue for 2025 to be $173,063,003, with the lowest IMCC revenue forecast at $173,063,003, and the highest IMCC revenue forecast at $173,063,003.
In 2026, IMCC is forecast to generate $195,278,257 in revenue, with the lowest revenue forecast at $195,278,257 and the highest revenue forecast at $195,278,257.